Crinetics Pharmaceuticals Inc (CRNX) stock news · rev $7.7M
Crinetics Pharmaceuticals Inc (CRNX) is a biotechnology company listed on US.
This CRNX news page leads with what Crinetics Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for CRNX yet. We will not pad this page with generic market recap.
Latest reported CRNX revenue for 2025-12-31 was $7.7M. Net income was -$465.3M. Revenue was up 640.7% from 2024-12-31 to 2025-12-31. CRNX currently screens at market cap $2.76B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CRNX stock page; for the tape open the quote page.
CRNX stock news FAQ
What are CRNX's latest revenue and net income?
Latest cached Crinetics Pharmaceuticals Inc (CRNX) revenue for Dec 31, 2025 was $7.7M. Net income was -$465.3M. Statements: https://lician.com/financials/crnx
How did CRNX revenue change from the prior cached period?
Cached Crinetics Pharmaceuticals Inc (CRNX) revenue was up 640.7% from $1.0M (Dec 31, 2024) to $7.7M (Dec 31, 2025). Statements: https://lician.com/financials/crnx
What is CRNX's market cap?
Crinetics Pharmaceuticals Inc (CRNX) market cap is $2.76B on the latest cached fundamentals snapshot.
What kind of company is CRNX?
Crinetics Pharmaceuticals Inc (CRNX) is a biotechnology company listed on US.
Where is CRNX stock news listed?
Cached stock news for Crinetics Pharmaceuticals Inc (CRNX) is listed at https://lician.com/news/crnx. Filings: https://lician.com/sec/crnx
Not investment advice.